Leonard S. Schleifer

2017

In 2017, Leonard S. Schleifer earned a total compensation of $26.5M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 6% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,468,160
Option Awards$21,967,210
Salary$1,285,500
Other$787,188
Total$26,508,058

Schleifer received $22M in option awards, accounting for 83% of the total pay in 2017.

Schleifer also received $2.5M in non-equity incentive plan, $1.3M in salary and $787.2K in other compensation.

Rankings

In 2017, Leonard S. Schleifer's compensation ranked 74th out of 14,666 executives tracked by ExecPay. In other words, Schleifer earned more than 99.5% of executives.

ClassificationRankingPercentile
All
74
out of 14,666
100th
Division
Manufacturing
15
out of 5,770
100th
Major group
Chemicals And Allied Products
5
out of 2,074
100th
Industry group
Drugs
4
out of 1,730
100th
Industry
Pharmaceutical Preparations
4
out of 1,329
100th
Source: SEC filing on April 26, 2019.

Schleifer's colleagues

We found three more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2017.

2017

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2017

Daniel Van Plew

Regeneron Pharmaceuticals

Executive Vice President and General Manager, Industrial Operations and Product Supply

2017

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like